SEC Comment Letter for PURPLE BIOTECH LTD. (PPBT) (CIK 0001614744) (PPBT) — Sep 24, 2019
PURPLE BIOTECH LTD. (PPBT) (CIK 0001614744)
Date: Sept. 24, 2019 · CIK: 0001614744 · Accession: 0000000000-19-013897
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-233795
Letter
September 24, 2019 Isaac Israel Chief Executive Officer Kitov Pharma Ltd. One Azrieli Center, Round Tower 132 Menachem Begin Road Tel Aviv 6701101, Israel Re:Kitov Pharma Ltd. Registration Statement on Form F-3 Filed September 16, 2019 File No. 333-233795 Dear Mr. Israel: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Sonia Bednarowski at 202-551-3666 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance
Show Raw Text
September 24, 2019
Isaac Israel
Chief Executive Officer
Kitov Pharma Ltd.
One Azrieli Center, Round Tower
132 Menachem Begin Road
Tel Aviv 6701101, Israel
Re:Kitov Pharma Ltd.
Registration Statement on Form F-3
Filed September 16, 2019
File No. 333-233795
Dear Mr. Israel:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Sonia Bednarowski at 202-551-3666 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance